ContractAgreement on Provision of Services and Premises for Execution of Clinical Study • January 11th, 2024
AGREEMENT ON PROVISION OF SERVICES AND PREMISES FOR EXECUTION OF CLINICAL STUDY This Agreement on Provision of Services and Premises for Execution of Clinical Study (“Agreement”) is effective as of the date of publishing in the Register of Contracts (“Effective Date”) between Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts 02210 USA, Company registration number [Tax ID: 043039129] as represented by Heidi Shea, Executive Director, Vendor and Business Management, appointing as its legal representative in the EU in accordance with Article 19 of EC Directive 2001/20/EC and Article 74 of EC Regulation 536/2014: Vertex Pharmaceuticals (Ireland) Limited with registered address at Unit 49, Block F2, Northwood Court, Santry, Dublin 9, D09 T665, Ireland (“Vertex”), and Fakultní nemocnice v Motole, Government contributory organisation, V Úvalu 84, 150 06 Praha 5, Czech Republic, Company registration number: 00064203, VAT No.: CZ00064203 as represented by MUDr. Marti
